ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 711077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 711077; 2) Community: the network communities that were significantly associated with the response to NSC 711077; 3) Molecule: the relationships between components within communities and NSC 711077; 4) MDR: the compounds that were significantly associated with the NSC 711077.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.022188614181866 0.081420858
NSC 269760 B8 0.022188614181866 0.2542719
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.022188614181866 0.2421072
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.022188614181866 0.16231466
NSC 339137 PHYSALOLACTONE 0.022188614181866 0.36829051
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.022188614181866 0.41979534
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.022188614181866 0.47883047
NSC 371777 Null 0.022188614181866 0.11153879
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.022188614181866 0.27013275
NSC 42972 Null 0.022188614181866 0.075138747
Total:109  Current:66    [First] [Prev] [Next] [Last]